RESULTS	More ezetimibe/simvastatin than atorvastatin patients with coronary heart disease ( CHD ) or CHD risk equivalents attained the ATP III LDL-C goal of < 100 mg/dL and the optional LDL-C target of < 70 mg/dL .\